Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gastrin Levels Linked to Helicobacter-Induced Stomach Cancer

By LabMedica International staff writers
Posted on 01 Jul 2009
Researchers working with mouse models have found that the stomach hormone gastrin is critically linked to the form of stomach cancer that may results from infection by Helicobacter bacteria.

Stomach cancer, which is the second leading cause of cancer-related deaths worldwide, has been strongly linked to Helicobacter infection. More...
These bacteria, which cause chronic inflammation of the stomach lining, infect nearly half of the world's population and have been shown to cause the development of gastric ulcers and stomach cancer.

In the current study, investigators from Columbia University Medical Center (New York, NY, USA) examined the influence of the stomach hormone gastrin, which is elevated by Helicobacter infection, on the development of stomach cancer. They worked with several mouse lines including gastrin-deficient (GAS-KO) mice and C57BL/6 wild-type mice. The animals were infected with H. felis for either 12 or 18 months and then examined for the presence of stomach cancer.

Results published in the July 2009 issue of The American Journal of Pathology revealed that neither too little nor too much gastrin was a healthy situation. Elevated levels of gastrin initiated development of tumors in the gastric corpus (main body of the stomach), but absence of gastrin also induced tumors in the gastric antrum, the lower section of the stomach that empties into the small intestine.

The bimodal effect of gastrin may be linked to the hormone's role in protecting the stomach mucosa from damage caused by gastric acid secretion induced by gastrin itself. Thus, either too much or too little gastrin could predispose a person to stomach cancer.

"Clinicians in the future may need to be more careful about prescribing acid-suppressive drugs for long-term use in patients infected with Helicobacter,” said senior author Dr. Timothy Wang, professor of Medicine at Columbia University Medical Center.

Related Links:

Columbia University Medical Center




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.